Penny Stocks
4 Likely Biotech Takeover Targets To Buy
After biotech stock Relypsa was bought out last week for a 60% premium, the odds of M&A heating up in this sector increased dramatically. Bret Jensen shares four more likely takeover targets that should be on your watchlist. It was a good week for the Biotech Gems portfolio. Progenics Pharmaceuticals (NASDAQ: PGNX) leapt 25% in […]
3 Stocks With Bullish Insider Buying
It’s this column’s second consecutive week of two minnows and a monster. Routinely, stocks that trade for under $10 and have insider buying are highlighted. But… once again, it was a struggle to find three small fish keepers. There is nuttin’ wrong with a wallhanger (taxidermed trophy fish) now and then. If not for a […]
Buy These 3 Stocks That Insiders Love
When the CEO of a company purchases $6 million worth of stock in short order, investors should take notice. Buys of that magnitude from insiders do not come around often. See the three stocks that have confident insider buying you shouldn’t ignore. Normally this column focuses on stocks with insider buying that trade for less […]
3 Stocks Under $10 With Bullish Insider Buying
Stocks with major insiders buying up shares are some of the most attractive investments in the market right now. With mounting uncertainty about what growth the economy can achieve in 2016, trusting in the people that know their businesses best is a safe bet. Investors are always interested in low priced stocks. That’s why you […]
3 Undervalued Stocks To Buy For Under $10
Buy shares in these three companies about to rally from their undervalued lows. Trading for under $10 each, these stocks are much too cheap for their growth prospects. In my last column I noted that I am becoming increasingly cautious on equities after the recent rally in the market. My cash allocation is up to […]
3 Small Cap Biotechs Ripe For A Takeover
Big biotech is about to go on a shopping spree to replenish their pipelines as many small cap biotechs are selling for lows not seen since 2011. Here are three likely candidates that might get snatched up soon for big premiums. Few sectors of the stock market have been hit harder in 2016 than the […]
Sell These 5 Stocks On The Verge Of Bankruptcy
These stocks have serious red flags and are ticking time bombs in your portfolio. Several companies from our 2014 and 2015 watchlists are already bankrupt or very close, and the companies profiled this year are likely on the same track. Dump these losers immediately. Bankruptcies — no one likes to talk about them, but they’re […]
Be Smarter Than the Smartest Investors
A couple times a year the biotech sector gives the retail investor the chance to look smarter than the “smart money” investor. That is, the retail investor can pick up shares of a promising biotech company at a better price than what the institutional investor paid. The institutional investor spent a lot of time and […]
Tiny Biotech Stock Set To Go Higher With Cure For Something Other Than Cancer
Traditionally, biotech investors are handsomely rewarded for owning shares of companies working on treatments for cancer, once approved by the FDA. Yet there is one company poised to skyrocket on a drug that cures a non-cancerous ailment. Sophiris Bio (SPHS, $1.67) is knocking on the door of an effective treatment for enlarged prostate. Located in […]
Find More Of The Best Penny Stocks In 2016
Want to find more of the best penny stocks in 2016? Be very, very picky. This is a time to be selective, to be demanding, and to ignore penny stocks where a lot of different things have to go right in order to make money. 2016 will be a year when you can expect things […]
